摘要
背景:放射疗法是普通和晚期肺癌患者最广泛使用的治疗方法。此外,放射治疗引起的临床毒性分为急性放射性肺炎和晚期肺纤维化。上皮 - 间质转化(EMT)是一个复杂的生理过程,涉及许多信号分子和蛋白质,如衔接蛋白和转录因子。它被确定为纤维化,伤口愈合和癌症的重要机制。辐射诱导的肺部EMT中出现了多种生物标志物,其中一些是获得性的(N-钙粘蛋白,波形蛋白和纤维连接蛋白等),其中一些在上皮细胞转变过程中被抑制(E-钙粘蛋白,zona occludens- 1)。 目的:在目前的综述中,我们强调了辐射诱导的肺EMT信号通路及其介质。我们还讨论了癌症,纤维化及其表观的EMT。 结果:辐射诱导的肺EMT受MAPK,NF-κB,Wnt,microRNA和组蛋白修饰等多种信号通路控制。转录因子如Snail,slug,twist,ZEB1(Zinc finger E-box binding-1)和ZEB2(Zinc finger E-box binding-2)蛋白是连接辐射诱导的EMT和纤维化的诱导物。表观遗传调节是基因组结构和功能的可遗传变化,其发生时序列没有任何变化。几种方法显示了表观遗传修饰及其抑制剂在控制纤维化和癌症中的作用。只有有限的报告集中于了解辐射诱导的肺部EMT的表观遗传调节。 结论:目前的综述重点关注辐射诱导的肺纤维化和EMT的最新发现,从而提供了重要信号通路的一些信息,其随后表达的基因和参与EMT的蛋白质。该综述还讨论了可用于治疗EMT相关疾病,即纤维化,癌症的各种抑制剂。
关键词: 辐射,EMT,表观遗传学,抑制剂,纤维化,信号通路。
图形摘要
Current Drug Targets
Title:Radiation-Induced Pulmonary Epithelial-Mesenchymal Transition: A Review on Targeting Molecular Pathways and Mediators
Volume: 19 Issue: 10
关键词: 辐射,EMT,表观遗传学,抑制剂,纤维化,信号通路。
摘要: Background: Radiotherapy is the most widely used treatment method for average and advanced lung cancer patients. Moreover, the clinical toxicities caused by radiotherapy are categorized into acute radiation pneumonitis and late pulmonary fibrosis. Epithelial-mesenchymal transition (EMT) is a complex physiological process involves many signaling molecules and proteins like adaptor proteins, and transcriptional factors. It was identified as a significant mechanism for fibrosis, wound healing and also cancer. A variety of biomarkers have appeared in radiation-induced lung EMT, some of which are acquired (N-cadherin, vimentin and fibronectin, etc.) and some of which are repressed during the transition of epithelial cells (E-cadherin, zona occludens-1).
Objective: In the current review, we highlighted the radiation-induced lung EMT signaling pathway and their mediators. We also discuss the EMT in cancer, fibrosis and its epigentics.
Results: Radiation-induced lung EMT is controlled by numerous signaling pathways like MAPK, NF- κB, Wnt, microRNAs and histone modifications. Transcriptional factors such as Snail, slug, twist, ZEB1 (Zinc finger E-box binding-1) and ZEB2 (Zinc finger E-box binding-2) proteins are inducers linking radiation-induced EMT and fibrosis. Epigenetic modulations are heritable changes in the structure and function of the genome that occurs without any change in the sequence. Several approaches showed the role of epigenetic modifications and its inhibitors in controlling fibrosis and cancer. Only limited reports are focused on understanding the epigenetic regulations of radiation-induced lung EMT.
Conclusion: The current review focused on recent findings regarding radiation-induced lung fibrosis and EMT, thus provides some information on important signaling pathways, its subsequent expression of genes and proteins involved in EMT. This review also discussed various inhibitors that could be used to treat EMT related diseases, i.e., fibrosis, cancer.
Export Options
About this article
Cite this article as:
Radiation-Induced Pulmonary Epithelial-Mesenchymal Transition: A Review on Targeting Molecular Pathways and Mediators, Current Drug Targets 2018; 19 (10) . https://dx.doi.org/10.2174/1389450119666180207092234
DOI https://dx.doi.org/10.2174/1389450119666180207092234 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
Current Molecular Medicine Associating Paracrine Communication to Regenerative Medicine: Search Strategies & Major Trends in Scientific and Patent Production
Recent Patents on Regenerative Medicine Angiotensin-Converting Enzyme 2 Roles in the Pathogenesis of COVID-19
Current Hypertension Reviews An Overview on Different Classes of Viral Entry and Respiratory Syncitial Virus (RSV) Fusion Inhibitors
Current Medicinal Chemistry Involvement of Leukotriene Pathway in the Pathogenesis of Ischemia- Reperfusion Injury and Septic and Non-Septic Shock
Current Vascular Pharmacology The Changing Face of Tobacco Use Among United States Youth
Current Drug Abuse Reviews Inhalation Delivery of Host Defense Peptides (HDP) using Nano- Formulation Strategies: A Pragmatic Approach for Therapy of Pulmonary Ailments
Current Protein & Peptide Science Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications
Current Pharmaceutical Design Anti-tumor Effects of Curcuminoids in Glioblastoma Multiforme: An Updated Literature Review
Current Medicinal Chemistry Cytochrome P450 2A6 Phenotyping Based on Dietary Caffeine Intake in a Japanese Population of Non-smokers
Drug Metabolism Letters Farnesylated Proteins as Anticancer Drug Targets: From Laboratory to the Clinic
Current Medicinal Chemistry - Anti-Cancer Agents The IGF Axis in Prostate Cancer
Current Pharmaceutical Design Gamma-Amino Butyric Acid Inhibits the Nicotine-Imposed Stimulatory Challenge in Xenograft Models of Non-Small Cell Lung Carcinoma
Current Cancer Drug Targets Cyclodextrin Inclusion Complexes Loaded in Particles as Drug Carrier Systems
Current Topics in Medicinal Chemistry Review of Procedures Used for the Extraction of Anti-Cancer Compounds from Tropical Plants
Anti-Cancer Agents in Medicinal Chemistry The Structure and Function of Histone Deacetylases: The Target for Anti-cancer Therapy
Current Medicinal Chemistry Overcoming Chemotherapy Resistance in High Grade Serous Ovarian Cancer
Current Cancer Therapy Reviews The Management of Metastatic Bone Disease with the Combination of Bisphosphonates and Radiotherapy: From Theory to Clinical Practice
Anti-Cancer Agents in Medicinal Chemistry Molecular Targets in Gastrointestinal Stromal Tumors (GIST) Therapy
Current Cancer Drug Targets Quality by Design Approach for Development and Optimization of Rifampicin Loaded Bovine Serum Albumin Nanoparticles and Characterization
Current Drug Delivery